Thursday, August 28, 2014 5:43:33 PM
Dr. Kaz,
Thanks to you and many others for correcting the misinformation regarding NNVC.
drkazmd65 Thursday, 08/28/14 11:48:45 AM
Re: Rawnoc post# 97677
Post # of 97708
As I said,.... The company (since many hypotheses that it has tested along the way are supported by the data) actually has 9+ years demonstrating almost exactly the opposite of failure. They have just not (yet) completed the final few steps needed to get a revenue stream going.
That'll happen soon enough.
Show us evidence that Dr. Diwan has made a 'pofit' in fronting the money to build the new Shelton, CT facility, and then selling it back to the company,....
Other than innuendo - there has been no such evidence submitted that can be vetted. The assumption that Dr. Diwan has scammed NNVC shareholders to his own benefit in doing this is merely conjecture. Show us some evidence to the contrary,....
The premise you make in this question of "doesn't the Dr. know when there will be enough Flucide for BASi" is a false one in that Dr. Seymour may (indeed) know when it is that we are likely to have enough Flucide to send it off to BASi,.... The company is under no obligation under SEC rules in telling 'us' what the specific timeline or expectation is. In fact - doing so could be viewed as an attempt to manipulate (positively or negatively) market perception of the stock prematurely.
Just because 'we' out here in the peanut gallery haven't been told what the timeline expectations are does not mean that the Company doesn't know.
What is going on pretty much does the opposite of 'defy logic and common sense'.
Thanks to you and many others for correcting the misinformation regarding NNVC.
drkazmd65 Thursday, 08/28/14 11:48:45 AM
Re: Rawnoc post# 97677
Post # of 97708
As I said,.... The company (since many hypotheses that it has tested along the way are supported by the data) actually has 9+ years demonstrating almost exactly the opposite of failure. They have just not (yet) completed the final few steps needed to get a revenue stream going.
That'll happen soon enough.
Show us evidence that Dr. Diwan has made a 'pofit' in fronting the money to build the new Shelton, CT facility, and then selling it back to the company,....
Other than innuendo - there has been no such evidence submitted that can be vetted. The assumption that Dr. Diwan has scammed NNVC shareholders to his own benefit in doing this is merely conjecture. Show us some evidence to the contrary,....
The premise you make in this question of "doesn't the Dr. know when there will be enough Flucide for BASi" is a false one in that Dr. Seymour may (indeed) know when it is that we are likely to have enough Flucide to send it off to BASi,.... The company is under no obligation under SEC rules in telling 'us' what the specific timeline or expectation is. In fact - doing so could be viewed as an attempt to manipulate (positively or negatively) market perception of the stock prematurely.
Just because 'we' out here in the peanut gallery haven't been told what the timeline expectations are does not mean that the Company doesn't know.
What is going on pretty much does the opposite of 'defy logic and common sense'.
Send illegal stock manipulators to:https://denebleo.sec.gov/TCRExternal/index.xhtml
Recent NNVC News
- Measles Rare Pediatric Disease Drug Designation Application Filed for NV-387, PRV Provides for Strong Business Case, Says NanoViricides • ACCESS Newswire • 04/07/2026 12:30:00 PM
- Phase II Clinical Trial of Monkeypox Treatment by NV-387 to Commence Soon, Announces NanoViricides • ACCESS Newswire • 04/01/2026 12:30:00 PM
- NanoViricides Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026 - Announces Manufacture of Phase II Clinical Product NV-387 Oral Gummies is Complete • ACCESS Newswire • 03/11/2026 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 09:30:47 PM
- MPox Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides • ACCESS Newswire • 02/12/2026 01:30:00 PM
- Measles Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides • ACCESS Newswire • 02/10/2026 01:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/30/2025 09:30:18 PM
- Form DEL AM - Delaying amendment • Edgar (US Regulatory) • 12/16/2025 09:30:05 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 12/15/2025 09:26:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/26/2025 09:30:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:32:10 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/12/2025 07:54:28 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/12/2025 04:29:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/01/2025 09:07:54 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/29/2025 08:33:17 PM
